Targeting Notch 3 Receptor Function Using Specific Peptides and Antipeptide Biomolecules

The present invention involves the use of peptides from Notch3, and antibodies that recognize epitopes represented by those peptides, as anti-cancer agents. Methods of combination therapy using standard anti-cancer protocols in conjunction with Notch3 peptides and antibodies also are provided.

U.S. Patent 7,807,630: Targeting of Notch3 receptor function for cancer therapy

Thao DangDavid CarboneRaymond MernaughDavid Blum
Licensing manager: 
Mike Villalobos

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter